SciClone Pharmaceuticals, Inc. (SCLN) Stock Analysis
DELISTED 2017
What happened to SciClone Pharmaceuticals, Inc. (SCLN) stock?
SciClone Pharmaceuticals, Inc. (SCLN) no longer trades on public markets. It was delisted in October 2017. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- October 2017
- Last recorded price (historical):
- $11.15 (last quote on record before the October 2017 delisting; historical, not a current quote)
P/E 18.28 means the share price is 18.28 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
SciClone Pharmaceuticals, Inc. (SCLN). SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company focused on acquiring, developing, and commercializing drugs for chronic and life-threatening diseases.
Last analyzed: Jun 15, 2026SciClone Pharmaceuticals, Inc. (SCLN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SCLN shares?
No. SCLN stopped trading on public markets in October 2017, so the shares are not available through a broker. Anything you see quoted for SCLN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SCLN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to SciClone Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.